Ascletis Pharma, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG0520K1094
HKD
14.52
-0.48 (-3.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'18
Net Sales
78.83
Other Operating Income
0.00
Total Operating income
78.83
Raw Material Cost
4.80
Purchase of Finished goods
0.00
(Increase) / Decrease In Stocks
0.00
Employee Cost
15.08
Power Cost
0.00
Manufacturing Expenses
0.00
Selling and Distribution Expenses
22.24
Other Expenses
2.86
Total Expenditure (Excl Depreciation)
70.74
Operating Profit (PBDIT) excl Other Income
8.100000000000001
Other Income
39.93
Operating Profit (PBDIT)
50.21
Interest
0.00
Exceptional Items
-20.34
Gross Profit (PBDT)
74.02
Depreciation
2.19
Profit Before Tax
27.68
Tax
0.00
Provisions and contingencies
0.00
Profit After Tax
27.68
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
27.68
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
27.68
Equity Capital
0.00
Face Value
0.0
Reserves
976.88
Earnings per share (EPS)
0.02
Diluted Earnings per share
0.02
Operating Profit Margin (Excl OI)
10.26%
Gross Profit Margin
37.89%
PAT Margin
35.11%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Quarterly Analysis Highlights - YoY
Markets Mojo
Analysis not available
Compare Quarterly Results Of Ascletis Pharma, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
78.83
0
78.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
78.83
0
78.83
Raw Material Cost
4.80
0
4.80
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
15.08
0
15.08
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
22.24
0
22.24
Other Expenses
2.86
0.00
2.86
Total Expenditure (Excl Depreciation)
70.74
0
70.74
Operating Profit (PBDIT) excl Other Income
8.09
0.00
8.09
Other Income
39.93
0
39.93
Operating Profit (PBDIT)
50.21
0
50.21
Interest
0.00
0
0.00
Exceptional Items
-20.34
0
-20.34
Gross Profit (PBDT)
74.02
0
74.02
Depreciation
2.19
0
2.19
Profit Before Tax
27.68
0
27.68
Tax
0.00
0
0.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
27.68
0
27.68
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
27.68
0
27.68
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
27.68
0
27.68
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
976.88
0
976.88
Earnings per share (EPS)
0.02
0
0.02
Diluted Earnings per share
0.02
0
0.02
Operating Profit Margin (Excl OI)
10.26%
0%
0.00
10.26%
Gross Profit Margin
37.89%
0%
0.00
37.89%
PAT Margin
35.11%
0%
0.00
35.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in

Figures in Million
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in

Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in

Figures in Million
Quarterly - Interest
Interest NA Million
in

Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %